N/A
Completed N=80
BPH-6: Comparison of the UroLift System to TURP for Benign Prostatic Hyperplasia
Source: ClinicalTrials.gov NCT01533038 ↗Enrolled (actual)
80
Serious AEs
7.5%
Results posted
Nov 2015
Primary outcomePrimary: Responder Analysis: A Subject is a Responder at the 12 Month Follow-up Time Point if All 6 Thresholds of the BPH-6 Endpoint Are Met — 52; 20 % Responders of Participants
Summary
The purpose of this study is to compare the UroLift System Treatment to Transurethral Resection of the Prostate (TURP) in improving a patient's overall quality of life, while evaluating healthcare expenditures associated with each therapy.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Responder Analysis: A Subject is a Responder at the 12 Month Follow-up Time Point if All 6 Thresholds of the BPH-6 Endpoint Are Met |
52; 20 | — |
Eligibility Criteria
Inclusion Criteria
- Men >50 years old with moderate-severe BPH
Exclusion Criteria
- Size, width of prostate
- Other medical condition or co-morbidity contraindicative for TURP or UroLift
Data sourced from ClinicalTrials.gov (NCT01533038). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.